Trial · NCT04184375
Cognitive Stimulation for Elderly Bipolar Patients
NCT04184375, Not applicable, Recruiting, Groupe Hospitalier de la Rochelle Ré Aunis
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Cognitive Stimulation for Elderly Bipolar Patients. Trials, record NCT04184375. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04184375
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Cognitive Stimulation for Elderly Bipolar Patients
- NCT number
- NCT04184375
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 40 participants, estimated
- Lead sponsor
- Groupe Hospitalier de la Rochelle Ré Aunis
- Conditions
- Bipolar Disorder, Cognitive Impairment, Age-related Cognitive Decline
- Interventions
- cognitive stimulation
- First posted
- 2019-12-03
- Last updated
- 2025-03-17
Source ClinicalTrials.gov
Registered outcomes21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Score at the Frontal Assessment Battery (FAB) | at 3 months after inclusion | The FAB assesses conceptualization (category responses, such as "in what way are a banana and an orange are alike?"), lexical fluency, programming or motor series (Luria), sensitivity to interference (conflicting instructions, such as "tap twice when I tap once"), inhibitory control (Go/No-Go), and environmental autonomy (prehension behavior, such as "do not take my hands") |
| Secondary | Score at FAB | at 6 months after inclusion | Scores between the 3-month and 6-month evaluation will determine whether executive analysis functions have been maintained |
| Secondary | Number of patients with a positive difference between the scores on the Functional Activities Questionnaire (QAF) | at inclusion | The QAF allows to quickly assess a patient's functional capacity and to identify a functional decline in the patient with a mild neurocognitive disorder, Alzheimer's disease or other neurocognitive disorder. |
| Secondary | Number of patients with a positive difference between the scores on the Functional Activities Questionnaire (QAF) | at 6 months after inclusion | A positive difference in scores reflects an improvement in patient autonomy |
| Secondary | Score at delayed matching-to-sample (DMS48) | at inclusion | The DMS48 is a test of visual recognition memory test |
| Secondary | Score at DMS48 | at 3 months after inclusion | The DMS48 is a test of visual recognition memory test |
| Secondary | Time in minutes at the Trail Making Test A (TMTA) | at inclusion | Evaluation of speed of processing. |
| Secondary | Time in minutes at the Trail Making Test A | at 3 months after inclusion | Evaluation of speed of processing. |
| Secondary | Number of errors at Trail Making Test B (TMTB) | at inclusion | Evaluation of mental flexibility |
| Secondary | Number of errors at Trail Making Test B (TMTB) | at 3 months after inclusion | Evaluation of mental flexibility |
1 to 10 of 21Source ClinicalTrials.gov
See all 21 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests6
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Go/No-Go Task | Primary outcome | ConductCognition |
| Delayed Match-to-Sample | Secondary outcome | ConductCognition |
| Recognition Memory Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04184375
GET https://conductscience.org/api/trials/v1/NCT04184375/registered?page=2